Cholesterol levels may be also reduced by Hsp25 immunotherapy, Hsp25 reduces plaque cholesterol by 30% and prevents experimental atherosclerosis in mice, which requires GM-CSF-regulated ABCA1 and ABCG1 expression (49). This evidence concerns the gene ABCA1 and atherosclerosis.